( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

The NIH's Jay Bhattacharya tried his best pitch to explain the Trump administration's shift away from mRNA vaccine research.

Jay Bhattacharya is director of the National Institutes of Health.

Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts ...

HHS canceled federal funding for mRNA vaccine development. Experts said this could affect our preparedness for future ...

The Department of Health and Human Services said it is winding down its mRNA vaccine-development activities under the ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

The U.S. Department of Health and Human Services said on Tuesday it would wind down mRNA vaccine development activities under ...

The U.S. Department of Health and Human Services said it would wind down mRNA vaccine development activities under its ...

Discover the potential consequences of mRNA vaccine development cuts on poultry health and infectious disease management in ...

In the video posted on X, Kennedy claimed mRNA vaccines were ineffective against mutated versions of the virus and revealed HHS is planning to reallocate the funding to research whole-virus vaccines, ...

The health secretary, who is a known vaccine skeptic, claimed that mRNA vaccines “fail to protect effectively against upper ...